Researchers led by Universitätsmedizin Frankfurt and Goethe University Frankfurt have identified how particularly aggressive ...

Objectives Treatment of rheumatoid arthritis (RA) relies on immunomodulatory drugs that can compromise immunity, inducing secondary immunodeficiency (SID). However, features of SID, such as ...

We present a middle childhood boy with type 1b diabetes mellitus (defined as insulin-dependent diabetes mellitus without ...

The high-grade glioma market is witnessing steady growth driven by the rising incidence of aggressive brain tumors, increasing awareness, and advancements ...

생쥐의 몸짓을 단어처럼 읽고 행동의 의미를 해석하는 인공지능(AI)이 개발됐다. 동물의 움직임을 단순히 분류하는 데서 나아가 자폐 모델 생쥐의 행동 특징까지 사전 지식 없이 찾아내는 데 성공했다. KAIST는 김대수 ...

Stoke Therapeutics, Inc. is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine and has a lead investigational medicine, zorevunersen ...

Blood-based T‑cell receptor sequencing reveals immune “fingerprints” in Lynch syndrome, helping track precancers early and paving the way for new cancer surveillance biomarkers. For Eduardo ...

Regulation to permit gene-edited plants has just passed in European Parliament, allowing genetic changes that don't introduce foreign DNA. The new rules aim to improve the food system by allowing gene ...

Zemcelpro® (dorocubicel), also known as UM171 Cell Therapy, recently received conditional marketing authorisation in Europe from the European Commission ...

Zemcelpro is a novel personalized cryopreserved hematopoietic stem cell transplantation product containing two components, namely UM171-expanded CD34+ cells (dorocubicel) and unexpanded CD34- cells, e ...

All Evaluable Patients Achieved Improvements in Multiple Hallmarks of MYBPC3-Associated HCM Benefits Among Cohort 1 Patients Sustained as Far Out ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...